FTC sues to block Edwards Lifesciences' $1.2B JenaValve deal. Edwards disputes, revises 2025 EPS guidance, and pursues ...

The U.S. Federal Trade Commission has sued to block Edwards Lifesciences Corp's acquisition of JenaValve Technology Inc, ...

Inc. ("Venus Medtech", Stock Code: 02500.HK) recently announced a decisive legal victory for its wholly-owned subsidiary ...

CEO Christian Mazzi said the minimally invasive surgical technique could provide better outcomes for patients than ...

Edwards Lifesciences may avoid bearishness but is likely to trade sluggishly through 2027, as key cycle phases signal limited ...

In its own statement, Edwards said it disagrees with the FTC’s belief that the acquisition will limit access to a new therapy ...

Detailed price information for Edwards Lifesciences Corp (EW-N) from The Globe and Mail including charting and trades.

Edwards Lifesciences and JenaValve said they remained committed to completing the deal and would defend the case in court.

Edwards Lifesciences announced that the U.S. Federal Trade Commission (FTC) seeks to block its planned $1.2 billion ...

Edwards Lifesciences Partners with LA Rams to Help Save Lives originally appeared on L.A. Mag.

Larry Wood, who was the executive behind building the biggest unit during his four decades at Edwards Lifesciences, is ...

Edwards Lifesciences Corp. closed 5.43% below its 52-week high of $83.00, which the company achieved on July 25th.